BIOAVAILABILITY STUDIES
Centre proposes tighter regulatory oversight of antimicrobials to tackle drug resistance
The Health Ministry has proposed amending the New Drugs and Clinical Trials Rules, 2019, to bring antimicrobials under Central regulatory oversight. The move would require manufacturers to secure prior approval from the Central Licensing Authority, addressing concerns over inadequate scrutiny and the growing threat of antimicrobial resistance.
Government to ease BA-BE study norms for domestic generic drug approvals, cut import licence timelines
Pharmaceutical companies will soon find it easier to conduct drug studies. Applicants can start eligible trials after intimating the drug regulator. This change aims to speed up the launch of generic drugs locally. Import licence applications for new drugs will also see reduced processing times. These measures are part of efforts to improve ease of doing business.
Centre proposes easier norms for faster drug rollout
India's government plans to streamline drug approval processes for domestic use. Applicants can now start studies after intimating the drug regulator. Import license processing timelines for new drugs will be halved to forty-five days. This move aims to improve the ease of doing business in the sector. However, certain high-risk drug categories will retain existing stringent requirements.
Boiled or Raw? The Best Way to Cook Broccoli to Keep More Vitamins and Antioxidants
Broccoli's health benefits depend on how it is cooked. Raw broccoli retains vitamin C but can be hard to digest. Boiling causes nutrient loss. Steaming is ideal, preserving vitamins and aiding absorption. Quick stir-frying and microwaving are also good options. Choosing the right method maximizes broccoli's wellness potential for everyone.
What Scientists Found Beneath the Southern Ocean Changes Climate Science
Scientists have uncovered new details about iron from Antarctic icebergs. This iron, once thought to boost ocean life and absorb carbon, is not dissolving as easily as believed. This challenges long-held ideas about the ocean's role in climate regulation. The findings suggest a more complex interplay of factors influences carbon uptake.
Centre set to amend rules to simplify drug testing process
The Indian government is amending drug regulations to expedite the approval process for clinical trials and bioavailability/bioequivalence studies. These changes aim to reduce the statutory processing time for test license applications from 90 to 45 days. By simplifying procedures and reducing the number of license applications, the government anticipates faster drug development and approval, benefiting stakeholders and optimizing resource allocation.

Torrent Pharma forays into OTC segment with calcium supplement
"With Shelcal's entry into OTC, the brand is poised to become the largest calcium supplement brand in India," Torrent Pharmaceuticals Director Aman Mehta said in a statement.

Optimus too could launch Covid pill Paxlovid soon
The company has conducted bioavailability and bioequivalence (BA/BE) studies and is likely to submit the safety data to the drug regulator this week for a review, said people aware of the matter.

Cipla to conduct study on Paxlovid
In its meeting held this week, the SEC granted approval to the company to conduct bioavailability and bio equivalence (BA/BE) studies. “Cipla will carry study on 44 participants and soon share data with the regulatory authority,” a government official said.

Nod for Paxlovid's Indian generic version to take longer
Hetero Labs and Optimus Pharma had approached the drug regulatory authority last month seeking waivers from conducting local trials. However, their proposal was turned down.

Primordial lightning strikes may have helped life emerge on Earth
Until now, it was widely thought that meteorites that bombarded early Earth were primarily responsible for the presence of "bioavailable" phosphorus. Some meteorites contain the phosphorus mineral called schreibersite, which is soluble in water, where life is thought to have formed.

Rhizen Pharmaceuticals gets USFDA approval for phase one clinical trials for Covid-19 drug
The Switzerland-based firm, which is a clinical-stage oncology-focussed biopharmaceutical company, has received approval for its investigational new drug (IND) application from the US Food and Drug Administration (FDA) to study its oral Dihydroorotate dehydrogenase (DHOHD) inhibitor for SARS-CoV-2 infection, Rhizen Pharmaceuticals S A said in a statement.

'Haldi' to the rescue! IIT Madras researchers show potential of turmeric in treating cancer
Treating leukaemia cells with curcumin results in cancer cells dying more.
Depression may reduce ariginine levels in your body
London, Feb 22 (IANS) People with major depressive disorder (MDD) have lower levels of naturally occurring arginine in their body than their non-depressed controls, a study has found.

Cipla’s inhalable insulin fails to get approval for trials on Indian patients
Cipla had based its application to the panel on the bioequivalence studies with Exubra, an inhalation drug and device combination that was being marked by Pfizer.

Panic signals in India as USFDA asks drug companies to repeat Semler’s studies
FDA inspections had found significant instances of misconduct and violations of federal regulations, including substitution and manipulation of study subject samples.

Drug applications based on Semler's data unacceptable: USFDA
The letter informs the sponsor that it must repeat the bioequivalence/bioavailability studies using an entity other than Semler at an acceptable alternate study site.

US Food and Drug Administration issues data integrity notice to Indian CRO Semler
This is another regulatory blow to the Indian drug industry, with several top pharmaceutical companies already under the watch of the US FDA for violation .
Drug regulator asks Sun Pharma to halt clinical research at Mumbai laboratory
The drug regulator took the step after discovering that Sun didn’t have the requisite approval from the central government for operating the laboratory.
Load More
